Document ID: chunk:federal_register_of_legislation:F2025L00212:clause:1_3436
Version: federal_register_of_legislation:F2025L00212
Segment Type: clause
Provision Reference: sch 1 cl 3436
Character Range: 1599318–1600687

3436                                      MYRISTICA FRAGRANS                                                                            A, E, H   Safrole is a mandatory component of Myristica fragrans.
                                                                                                                                                  When for internal use then the concentration of safrole in the medicine must be no more than 0.1%.
                                                                                                                                                  When for topical use then the concentration of safrole in the medicine must be no more than 1%.
                                                                                                                                                  When the plant preparation is oil or distillate and the concentration in the medicine is more than 50%, the nominal capacity of the container must be no more than 25 millilitres, the medicine must have a restricted flow insert fitted on the container and requires the following warning statement on the medicine label:
                                                                                                                                                  - (CHILD) 'Keep out of reach of children' (or word to that effect).